Tenapanor administration and the activity of the H+-coupled transporter PepT1 in healthy volunteers-Reference-Cited by-同舟云学术

Tenapanor administration and the activity of the H+-coupled transporter PepT1 in healthy volunteers

Published:2017-05-31 Issue:9 Volume:83 Page:2008-2014
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Johansson Susanne¹,Rosenbaum David P.²^ORCID,Palm Johan³,Stefansson Bergur⁴,Knutsson Mikael⁵,Lisbon Eleanor A.⁶,Hilgendorf Constanze⁷

Affiliation:

1. Quantitative Clinical Pharmacology, Innovative Medicines and Early Development Biotech Unit; AstraZeneca; Mölndal Sweden

2. Ardelyx Inc.; Fremont CA USA

3. Product Development, Pharmaceutical Technology & Development, Operations; AstraZeneca; Mölndal Sweden

4. Cardiovascular Metabolic Diseases, Global Medicines Development; AstraZeneca; Mölndal Sweden

5. Biometrics & Information Sciences, Global Medicines Development; AstraZeneca; Mölndal Sweden

6. QuintilesIMS; Overland Park KS USA

7. Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit; AstraZeneca; Mölndal Sweden

Funder

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13313/fullpdf

Reference36 articles.

1. The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucl Acids Res,2016

2. The Concise guide to PHARMACOLOGY 2015/16: Transporters;Alexander;Br J Pharmacol,2015

3. Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans;Spencer;Sci Transl Med,2014

4. Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger;Schultheis;Nat Genet,1998

5. Cloning and sequencing of a rabbit cDNA encoding an intestinal and kidney-specific Na+/H+ exchanger isoform (NHE-3);Tse;J Biol Chem,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor;International Journal of Nephrology and Renovascular Disease;2024-05

2. Renal Osteodystrophy: Clinical Management;Endocrinology;2023-12-19

3. A pharmacokinetic evaluation of tenapanor for the treatment of irritable bowel syndrome with constipation: an update of the literature;Expert Opinion on Drug Metabolism & Toxicology;2023-12-02

4. Efficacy and safety of tenapanor in hemodialysis patients with hyperphosphatemia: A systematic review and meta‐analysis of randomized placebo‐controlled trials;Therapeutic Apheresis and Dialysis;2023-06-22

5. The Physiological Function and Potential Role of the Ubiquitous Na+/H+ Exchanger Isoform 8 (NHE8): An Overview Data;International Journal of Molecular Sciences;2022-09-17